“Unraveling the Legal Labyrinth: Can AI Revolutionize Pharma Without Copyright Catastrophes?”

"Unraveling the Legal Labyrinth: Can AI Revolutionize Pharma Without Copyright Catastrophes?"

Our experts broke these risks down into two broad categories — legal and reputational. In addition to copyright infringement, patent infringement is a major concern, warns Chris McSpiritt, vice president of life sciences strategy at Domino Data Lab. Drugs are patented based on their molecular structure; if an AI model suggests a treatment candidate patented by a competitor — perhaps due to its unintentional inclusion in a third-party dataset — this could lead to inadvertent patent infringement. Without safeguards, companies may unknowingly invest in R&D for a product they cannot legally develop. McSpiritt notes that many organizations already have processes for checking patent conflicts, and the introduction of AI reinforces the importance of proficiency in this area.

Pages: 1 2 3 4 5 6 7 8 9 10 11

You May Have Missed